Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Zejula“
Suchtreffer
Begriffe & Kennungen
Zejula · 4.5 · Inhibition of efflux transporters [P-glycoprotein (P-gp), Breast Cancer Resistance Protein (BCRP) and MATE1/2K
Eintrag öffnenZejula · 4.5 · Niraparib is an inhibitor of MATE1 and -2K in vitro. Plasma concentrations of metformin may increase when conc
Eintrag öffnenZejula · 4.5 · Niraparib is an inhibitor of MATE1 and -2K in vitro. Plasma concentrations of metformin may increase when conc
Eintrag öffnenZejula · 4.5 · No clinical drug interaction studies have been performed with niraparib.
Eintrag öffnenZejula · 4.5 · No clinical drug interaction studies have been performed with niraparib.
Eintrag öffnenZejula · 4.5 · Pharmacodynamic interactions
Eintrag öffnenZejula · 4.5 · Pharmacodynamic interactions
Eintrag öffnenZejula · 4.5 · Pharmacokinetic interactions
Eintrag öffnenZejula · 4.5 · Pharmacokinetic interactions
Eintrag öffnenZejula · 4.5 · The combination of niraparib with vaccines or immunosuppressant agents has not been studied.
Eintrag öffnenZejula · 4.5 · The combination of niraparib with vaccines or immunosuppressant agents has not been studied.
Eintrag öffnenZejula · 4.5 · The data on niraparib in combination with cytotoxic medicinal products are limited. Therefore, caution should
Eintrag öffnenZejula · 4.5 · The data on niraparib in combination with cytotoxic medicinal products are limited. Therefore, caution should
Eintrag öffnenZejula · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenZejula · 4.6 Fertility, pregnancy and lactation · 2
Eintrag öffnenZejula · 4.8 Undesirable effects · 1
Eintrag öffnenZejula · 4.8 Undesirable effects · 2
Eintrag öffnenZejula · 4.8 · 10 In NOVA and PRIMA, patients eligible for Zejula therapy had the following baseline haematologic parameters:
Eintrag öffnenZejula · 4.8 · 11 placebo-treated patients with a median time from first dose to first onset of 29 days (range: 15 to 421 day
Eintrag öffnenZejula · 4.8 · 30 Table 4: Tabulated list of adverse reactions System organ class Frequency of all CTCAE Frequency of CTCAE g
Eintrag öffnen